Prevalence of COVID-19 Infection in a Cohort of Patients Infected by the HIV and Patients Taking PrEP

Prevalence of COVID-19 Infection in a Cohort of Patient Infected by the HIV and Patients Taking PrEP Pre-exposure Prophylaxis

The purpose of the study is to assess seroprevalence of COVID-19 infection in a cohort of HIV + patients and in a cohort of patients taking PrEP by emtricitabine / tenofovir.

Inclusion Criteria:

• Aged ≥ 18 years
• patients infected by the HIV on treatment
• patients taking PreP (Pre-exposure prophylaxis (PrEP))
• Being affiliated with or benefiting from a social security scheme

Exclusion Criteria:

• Subject to a measure for the protection of justice